Nakagawa, Masatsugu, Nishimura, Tsutomu, Teramukai, Satoshi, Tada, Harue, Tanaka, Fumihiro, Yanagihara, Kazuhiro, ...
Abstract Background In Japan, high incidences of interstitial lung disease (ILD) and ILD-related deaths have been reported among gefitinib-treated patients with non-small cell lung cancer (NSCLC). We...
Tada, Harue, Teramukai, Satoshi, Fukushima, Masanori, Sasaki, Hiroshi
Abstract Background Lymph node dissection has proven prognostic benefits for patients with ovarian or uterine carcinoma; however, one of the complications associated with this procedure is...
Nishimura, Tsutomu, Tada, Harue, Nakagawa, Masatsugu, Teramukai, Satoshi, Matsui, Shigeyuki
Objective: The objective of this study was to identify problems in the approval, pharmacovigilance, and post-approval regulatory decision-making procedures involving gefitinib and to propose...